Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Operating Activities:
Net loss	$ (10,293,859)	$ (21,693,465)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	701,976	2,757,559
Share based compensation	95,911	557,980
Realized gain on sale of assets	(1,214,659)	0
Amortization of financing costs to interest expense	70,557	104,679
Write down of previously capitalized inventory	363,758	0
Non-cash interest expense	727,734	206,845
Amortization of debt discount	3,190,184	3,006,096
Change in fair value of derivatives and gain/loss on extinguishment of liabilities, net	(1,601,987)	3,428,426
Inducement conversion costs	635,514	0
Bad debt expense	9,649	182,716
Changes in operating assets and liabilities:
Accounts receivable	396,467	978,972
Inventories	1,010,196	195,859
Prepaid expenses and other current assets	355,759	475,827
Accounts payable	(340,200)	(344,269)
Related party payable	(14,903)	0
Accrued expenses	(26,868)	(124,771)
Accrued litigation settlement	(289,861)	(264,411)
Warranty reserve	(50,085)	(28,611)
Net cash used in operating activities	(6,274,717)	(10,560,568)
Investing Activities:
Purchase of property, plant and equipment	0	20,688
Proceeds from the sale of assets	150,000	0
Patent activity costs	(25,341)	(96,344)
Deposit on building	0	0
Net cash provided by/(used in) investing activities	124,659	(117,032)
Financing Activities:
Payment of debt financing costs	0	(40,000)
Repayment of debt	(862,993)	(157,862)
Proceeds from promissory note	2,865,000	0
Proceeds from Committed Equity Line	0	1,056,147
Proceeds from issuance of stock and warrants	4,250,000	9,625,000
Net cash provided by financing activities	6,252,007	10,483,285
Net change in cash and cash equivalents	101,949	(194,315)
Cash and cash equivalents at beginning of period	130,946	326,217
Cash and cash equivalents at end of period	232,895	131,902
Supplemental Cash Flow Information:
Cash paid for interest	206,080	192,532
Non-Cash Transactions:
Non-cash conversions of preferred stock and convertible notes to equity	6,934,064	7,745,950
Make-whole provision on convertible preferred stock	257,152	0
Non-cash financing costs	2,500	0
Accounts payable converted to notes payable	1,422,026	0
Accounts payable forgiven related to sale of EnerPlex	$ 1,031,726	$ 0